Nexalin Technology Share Price Today
(NASDAQ: NXL)

Name: Nexalin Technology Share Price Today (NASDAQ: NXL) - Nexalin Technology Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Nexalin Technology share price is $2.43 & ₹211.33 as on 6 Mar 2025, 2.30 'hrs' IST

$2.43

Market is closed - opens 8 PM, 06 Mar 2025

View live Nexalin Technology share price in Dollar and Rupees. Guide to invest in Nexalin Technology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Nexalin Technology, along with analyst recommendations, forecasts, and comprehensive financials.

Nexalin Technology share price movements

Today's Low: $2.37
Today's High: $2.49
$2.43
2.47%
Downside
Day's Volatility :4.82%
Upside
2.41%
52 Weeks Low: $0.30
52 Weeks High: $4.49
$2.43
87.5%
Downside
52 Weeks Volatility :93.23%
Upside
45.88%

Nexalin Technology (NXL) Returns

Period	Nexalin Technology Inc	Index (Russel 2000)
3 Months	-41.73%	0.0%
6 Months	186.02%	0.0%
1 Year	367.31%	0.0%
3 Years	8.0%	-11.6%

Nexalin Technology (NXL) Key Statistics

in dollars & INR

Previous Close	$2.43
Open	$2.45
Today's High	$2.49
Today's Low	$2.37
Market Capitalization	$32.3M
Today's Volume	$5.5K
52 Week High	$4.4899
52 Week Low	$0.3038
Revenue TTM	$162.1K
EBITDA	$-6.5M
Earnings Per Share (EPS)	$-0.64
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-135.57%

How to invest in Nexalin Technology Stock (NXL) from India?

It is very easy for Indian residents to invest directly in Nexalin Technology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nexalin Technology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nexalin Technology or NXL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nexalin Technology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nexalin Technology shares which would translate to 0.358 fractional shares of Nexalin Technology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Nexalin Technology, in just a few clicks!

Returns in Nexalin Technology (NXL) for Indian investors in Rupees

The Nexalin Technology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Nexalin Technology investment value today

Current value as on today

₹4,72,270

Returns

₹3,72,270

(+372.27%)

Returns from Nexalin Technology Stock

₹3,67,308 (+367.31%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Nexalin Technology (NXL)

28%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Nexalin Technology Stock from India on INDmoney has increased by 28% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Nexalin Technology

Analyst Forecast on Nexalin Technology Stock (NXL)

What analysts predicted

Upside of 23.46%

Target:

$3.00

Current:

$2.43

Insights on Nexalin Technology Stock (Ticker Symbol: NXL)

Price Movement
In the last 1 year, NXL stock has moved up by 598.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 26.84K → 36.03K (in $), with an average increase of 25.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, -780.66K → -2.44M (in $), with an average decrease of 49.1% per quarter

NXL Nexalin Technology Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$207.4K	-
Net Income	$-5.0M	-
Net Profit Margin	-2.4K%	-

	FY20	Y/Y Change
Revenue	$242.9K	↑ 17.13%
Net Income	$-3.5M	↓ 30.65%
Net Profit Margin	-1.4K%	↑ 987.72%

	FY21	Y/Y Change
Revenue	$144.1K	↓ 40.69%
Net Income	$-6.2M	↑ 76.91%
Net Profit Margin	-4.3K%	↓ 2842.57%

	FY22	Y/Y Change
Revenue	$1.3M	↑ 817.2%
Net Income	$-1.9M	↓ 68.74%
Net Profit Margin	-145.75%	↑ 4130.32%

	FY23	Y/Y Change
Revenue	$110.7K	↓ 91.62%
Net Income	$-4.6M	↑ 141.39%
Net Profit Margin	-4.2K%	↓ 4051.81%

	Q2 FY23	Q/Q Change
Revenue	$35.5K	↑ 16.3%
Net Income	$-822.4K	↑ 15.89%
Net Profit Margin	-2.3K%	↑ 8.01%

	Q3 FY23	Q/Q Change
Revenue	$24.1K	↓ 32.15%
Net Income	$-2.3M	↑ 179.31%
Net Profit Margin	-9.5K%	↓ 7212.65%

	Q4 FY23	Q/Q Change
Revenue	$20.5K	↓ 14.83%
Net Income	$-780.7K	↓ 66.02%
Net Profit Margin	-3.8K%	↑ 5725.3%

	Q1 FY24	Q/Q Change
Revenue	$78.7K	↑ 283.09%
Net Income	$-1.0M	↑ 33.37%
Net Profit Margin	-1.3K%	↑ 2478.04%

	Q2 FY24	Q/Q Change
Revenue	$26.8K	↓ 65.88%
Net Income	$-1.3M	↑ 23.37%
Net Profit Margin	-4.8K%	↓ 3462.31%

	Q3 FY24	Q/Q Change
Revenue	$36.0K	↑ 34.24%
Net Income	$-2.4M	↑ 90.6%
Net Profit Margin	-6.8K%	↓ 2009.12%

	FY19	Y/Y Change
Profit	$-10.8K	-

	FY20	Y/Y Change
Profit	$213.9K	↓ 2075.39%

	FY21	Y/Y Change
Profit	$122.6K	↓ 42.67%

	FY22	Y/Y Change
Profit	$958.1K	↑ 681.37%

	FY23	Y/Y Change
Profit	$85.1K	↓ 91.12%

	Q2 FY23	Q/Q Change
Profit	$26.2K	↑ 11.58%

	Q3 FY23	Q/Q Change
Profit	$20.1K	↓ 23.03%

	Q4 FY23	Q/Q Change
Profit	$-406.6K	↓ 2118.98%

	Q1 FY24	Q/Q Change
Profit	$-256.9K	↓ 36.82%

	Q2 FY24	Q/Q Change
Profit	$-287.9K	↑ 12.06%

	Q3 FY24	Q/Q Change
Profit	$23.3K	↓ 108.11%

	FY19	Y/Y Change
Operating Cash Flow	$-678.3K	-
Investing Cash Flow	$-648.0	-
Financing Cash Flow	$726.1K	-

	FY20	Y/Y Change
Operating Cash Flow	$-863.5K	↑ 27.29%
Investing Cash Flow	$-648.0	↑ 0.0%
Financing Cash Flow	$879.1K	↑ 21.08%

	FY21	Y/Y Change
Operating Cash Flow	$-1.1M	↑ 24.7%
Investing Cash Flow	$-6.8M	↑ 1048492.44%
Financing Cash Flow	$1.7M	↑ 88.84%

	FY22	Y/Y Change
Operating Cash Flow	$-2.2M	↑ 105.77%
Investing Cash Flow	$-6.8M	↑ 0.0%
Financing Cash Flow	$8.5M	↑ 412.7%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-815.6K	↓ 37.96%
Investing Cash Flow	$872.4K	↑ 0.0%
Financing Cash Flow	$0.0	↓ 100.0%

Nexalin Technology Technicals Summary

Sell

Neutral

Buy

Nexalin Technology is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Nexalin Technology (NXL) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Nexalin Technology Inc	-20.59%	186.02%	367.31%	8.0%	8.0%
Medtronic Plc	2.26%	4.07%	8.74%	-12.76%	0.68%
Edwards Lifesciences Corp.	0.07%	8.12%	-19.19%	-34.12%	12.08%
Boston Scientific Corp.	0.07%	27.33%	53.68%	143.5%	203.93%
Stryker Corporation	-0.63%	8.92%	9.84%	53.87%	125.87%
Abbott Laboratories	7.11%	21.64%	15.28%	15.75%	78.63%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Nexalin Technology Inc	NA	NA	NA	-0.61	-1.36	-0.84	NA	0.39
Medtronic Plc	28.75	28.75	1.87	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	30.5	30.5	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	83.9	83.9	1.85	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.89	50.89	2.85	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Nexalin Technology Inc	NA	$32.3M	8.0%	NA	0.0%
Medtronic Plc	Buy	$120.9B	0.68%	28.75	12.83%
Edwards Lifesciences Corp.	Buy	$42.0B	12.08%	30.5	76.75%
Boston Scientific Corp.	Buy	$154.8B	203.93%	83.9	11.07%
Stryker Corporation	Buy	$150.7B	125.87%	50.89	13.25%
Abbott Laboratories	Buy	$238.6B	78.63%	18.34	31.95%

About Nexalin Technology

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Organization	Nexalin Technology
Employees	6
CEO	Mr. Mark White
Industry	Miscellaneous

Management People of Nexalin Technology

Name	Title
Mr. Mark White	President, CEO, CFO & Director
Dr. David Owens M.D.	Chief Medical Officer & Director
Ms. Marilyn Elson	Controller
Mr. John Patrick Claude	Co-Founder and Director of Engineering & Development
Ms. Carolyn Shelton	Senior Vice President of Quality, Regulatory & Clinical Affairs

Important FAQs about investing in NXL Stock from India :

What is Nexalin Technology share price today?

Nexalin Technology share price today stands at $2.43, Open: $2.45 ; Previous Close: $2.43 ; High: $2.49 ; Low: $2.37 ; 52 Week High: $4.49 ; 52 Week Low: $0.30.

The stock opens at $2.45, after a previous close of $2.43. The stock reached a daily high of $2.49 and a low of $2.37, with a 52-week high of $4.49 and a 52-week low of $0.30.

Can Indians buy Nexalin Technology shares?

Yes, Indians can invest in the Nexalin Technology (NXL) from India.

With INDmoney, you can buy Nexalin Technology at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Nexalin Technology at zero transaction cost.

How can I buy Nexalin Technology shares from India?

It is very easy to buy Nexalin Technology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nexalin Technology (NXL) be purchased?

Yes, you can buy fractional shares of Nexalin Technology with INDmoney app.

What are the documents required to start investing in Nexalin Technology stocks?

To start investing in Nexalin Technology, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.